Comamonas aquatica diet inhibits TIR-1/SARM1-induced axon degeneration by providing vitamin B12
Cell Reports · 2026-11 · 45 (11) · 118092
DOI: 10.1016/j.celrep.2026.118092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-11. Verfasst von Lauren C O'Connor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Neuroscience Program, Morningside Graduate Sch…. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Emerging evidence suggests the microbiome critically influences the onset and progression of neurodegenerative diseases; however, the identity of neuroprotective bacteria and the molecular mechanisms that respond within the host remain largely unknown. Here, we leverage Caenorhabditis elegans' well-characterized nervous system and ability to eat uni-bacterial diets to determine how metabolites and neuroprotective molecules from single species of bacteria suppress degeneration of motor neurons. We find that Comamonas aquatica significantly protects against degeneration induced by overexpressing a key regulator of axon degeneration, TIR-1/SARM1. Genetic analyses and metabolomics reveal Comamonas protects against neurodegeneration by providing sufficient vitamin B12 to activate METR-1/MTR methionine synthase in the intestine, which then lowers toxic levels of homocysteine in TIR-1-expressing animals. Defining a molecular pathway between Comamonas and neurodegeneration adds significantly to our understanding of gut-brain interactions and, given the prominent role of homocysteine in neurodegenerative disorders, reveals how such a bacterium could protect against disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Neuroscience Program, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School, Worcester, MA 0…
- Department of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
- Program in Molecular Medicine, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School, Worcester, MA 01605, USA.
- Howard Hughes Medical Institute at UMass Chan Medical School, Worcester, MA 01605, USA.
- Department of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: alexandra.byrne@umassmed.edu.
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
O'Connor, L. C., Kang, W. K., Vo, P., Spinelli, J. B., Alkema, M. J., & Byrne, A. B. (2026). Comamonas aquatica diet inhibits TIR-1/SARM1-induced axon degeneration by providing vitamin B12. Cell Reports, 45(11), 118092. https://doi.org/10.1016/j.celrep.2026.118092
Vancouver
O'Connor LC, Kang WK, Vo P, Spinelli JB, Alkema MJ, Byrne AB. Comamonas aquatica diet inhibits TIR-1/SARM1-induced axon degeneration by providing vitamin B12. Cell Reports. 2026;45(11):118092. doi:10.1016/j.celrep.2026.118092
BibTeX
@article{OConnor2026,
author = {O'Connor, Lauren C and Kang, Woo Kyu and Vo, Paula and Spinelli, Jessica B and Alkema, Mark J and Byrne, Alexandra B},
title = {Comamonas aquatica diet inhibits TIR-1/SARM1-induced axon degeneration by providing vitamin B12},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {11},
pages = {118092},
doi = {10.1016/j.celrep.2026.118092}
}
EUVIMED